PREVALENCE OF CLAUDIN18.2 AND PD-L1 EXPRESSION IN CHINESE GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

被引：1
|
作者：
Mao, Linlin [1 ]
Yi, Wei [1 ]
Lin, Xu-Alan [1 ]
Gu, Ying [1 ]
Xia, Zhenzhong [1 ]
Qi, Chuan [1 ]
Shi, Michael [1 ]
Yu, Steven [1 ]
Qian, Xueming [1 ]
机构：
[1] Suzhou Transcenta Therapeut Co Ltd, Suzhou, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [41] Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers: Results from the FAST study.
    Schuler, Martin H.
    Al-Batran, Salah-Eddin
    Zvirbule, Zanete
    Manikhas, Georgy
    Lordick, Florian
    Rusyn, Andriy V.
    Vynnychenko, Ihor
    Dudov, Assen
    Bazin, Igor
    Melichar, Bohuslav
    Dhaene, Karl
    Wiechen, Kai
    Maurus, Daniel
    Tureci, Ozlem
    Sahin, Ugur
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Protein expression of claudin 18.2, Nectin-4, HER-3, and PD-L1 in small bowel adenocarcinoma: Exploring potential targets of antibody drugs
    Fujii, Hiroyuki
    Shoji, Hirokazu
    Hirano, Hidekazu
    Hirose, Toshiharu
    Okita, Natsuko Tsuda
    Takashima, Atsuo
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] PD-L1 expression in EBV-negative gastric adenocarcinoma and clinicopathological analysis
    Fu, Y.
    Shi, Q.
    Wu, H.
    Fan, X.
    VIRCHOWS ARCHIV, 2018, 473 : S164 - S164
  • [44] High Prevalence of Claudin 18.2 Expression in Japanese Patients with Gastric Cancer.
    Tureci, Ozlem
    Itoh, Kyogo
    Yamaguchi, Rin
    Mukhina, Svetlana
    Sahin, Ugur
    Rohde, Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] PD-L1 expression in EBV-negative gastric adenocarcinoma and clinicopathological analysis
    Fu, Yao
    Shi, Qianyun
    Wu, Hongyan
    Fan, XiangShan
    LABORATORY INVESTIGATION, 2018, 98 : 262 - 262
  • [46] PD-L1 expression in EBV-negative gastric adenocarcinoma and clinicopathological analysis
    Fu, Yao
    Shi, Qianyun
    Wu, Hongyan
    Fan, XiangShan
    MODERN PATHOLOGY, 2018, 31 : 262 - 262
  • [47] Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma
    Kim, Dong Hyun
    Bae, Go Eun
    Suh, Kwang Sun
    Ryuman, David
    Song, Kyu Sang
    Kim, Ju Seok
    Lee, Sang-Il
    Yeo, Min-Kyung
    IN VIVO, 2020, 34 (06): : 3171 - 3180
  • [48] PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance
    Lian, Jie
    Zhang, Guanjun
    Zhang, Yun
    Liu, Heng
    Zhang, Jiaojiao
    Nan, Pengfei
    Tian, Wei
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (10) : 1419 - 1427
  • [49] PD-L1 EXPRESSION IN SUBTYPES OF ADENOCARCINOMA OF THE LUNG
    Son, Choonhee
    CHEST, 2019, 156 (04) : 307A - 307A
  • [50] Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis
    Yuan, Zhen
    Cui, Hao
    Wang, Shuyuan
    Liang, Wenquan
    Cao, Bo
    Song, Liqiang
    Liu, Guibin
    Huang, Jun
    Chen, Lin
    Wei, Bo
    FRONTIERS IN ONCOLOGY, 2023, 13
12345